European and Developing Countries Clinical Trials Partnership
OrganisationROR
Trials
Collaborator, Phase 3, Recruiting, 610 people, 12 Jan 2024
Collaborator, Phase 3, Recruiting, 768 people, 30 Oct 2019
Collaborator, Phase 1/2, Completed, 78 people, 2 Aug 2019
Collaborator, Phase 3, Completed, 240 people, 16 Aug 2013
Collaborator, Phase 2, Completed, 120 people, 26 Oct 2012
Collaborator, Phase 3, Completed, 1,500 people, 21 Mar 2008
Awards made
TMA, Evaluating the Impact of Metformin on Mycobacterium tuberculosis Growth in Macrophages, TMA2019CDF-2709, 2020–2023, 1 Sept 2020
Centre for the AIDS Programme of Research in South Africa
TMA, Evaluating the Impact of Metformin on Mycobacterium tuberculosis Growth in Macrophages, TMA2019CDF-2709, €141.6k, 2020–2023, 1 Sept 2020
RIA, Preventing and delaying the development of diabetes in Africa: a randomised placebo-controlled double-blind phase III trial of metformin in HIV-infected persons with pre-diabetes, RIA2018CO-2513, 2020–2024, 1 Apr 2020
RIA, Preventing and delaying the development of diabetes in Africa: a randomised placebo-controlled double-blind phase III trial of metformin in HIV-infected persons with pre-diabetes, RIA2018CO-2513, €4m, 2020–2024, 1 Apr 2020
TMA, Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes, and Association with Inflammation and ACEI/ARB Use in a Clinical Setting, TMA2017CDF-1928, 2019–2022, 1 Jul 2019
TMA, Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes, and Association with Inflammation and ACEI/ARB Use in a Clinical Setting, TMA2017CDF-1928, €148.4k, 2019–2022, 1 Jul 2019
TMA, Diagnosis and treatment of non-communicable diseases and geriatric syndromes in the HIV aging population in sub-Saharan Africa., TMA2017GSF-1936, 2019–2024, 1 Apr 2019
Sources: openalex.org